Control of liver cell fate decision by a gradient of TGFβ signaling modulated by Onecut transcription factors

  1. Frédéric Clotman1,
  2. Patrick Jacquemin1,
  3. Nicolas Plumb-Rudewiez1,
  4. Christophe E. Pierreux1,
  5. Patrick Van der Smissen2,
  6. Harry C. Dietz3,
  7. Pierre J. Courtoy2,
  8. Guy G. Rousseau1, and
  9. Frédéric P. Lemaigre1,4
  1. 1Hormone and Metabolic Research Unit, 2Cell Biology Unit, Institute of Cellular Pathology and Université catholique de Louvain, 1200 Brussels, Belgium; 3Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

Abstract

During liver development, hepatocytes and biliary cells differentiate from common progenitors called hepatoblasts. The factors that control hepatoblast fate decision are unknown. Here we report that a gradient of activin/TGFβ signaling controls hepatoblast differentiation. High activin/TGFβ signaling is required near the portal vein for differentiation of biliary cells. The Onecut transcription factors HNF-6 and OC-2 inhibit activin/TGFβ signaling in the parenchyma, and this allows normal hepatocyte differentiation. In the absence of Onecut factors, the shape of the activin/TGFβ gradient is perturbed and the hepatoblasts differentiate into hybrid cells that display characteristics of both hepatocytes and biliary cells. Thus, a gradient of activin/TGFβ signaling modulated by Onecut factors is required to segregate the hepatocytic and the biliary lineages.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.340305.

  • 4 Corresponding author.

    4 E-MAIL lemaigre{at}horm.ucl.ac.be; FAX 32-2-764-75-07.

    • Accepted June 14, 2005.
    • Received February 14, 2005.
| Table of Contents

Life Science Alliance